NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Esperion Stock Surges 57% as ARCHIMED Acquires Company for $1.1 Billion

ARCHIMED will buy Esperion and take it private for $3.16/share (+58% premium) plus up to $100M extra payouts if targets are met.

Esperion Stock Surges 57% as ARCHIMED Acquires Company for $1.1 Billion
Credit: Esperion
Already have an account? Sign in.
Featured/ 05/01/2026 · 8:37 AM
ESPR
/ Don’t stop at just one post.

Related↓

09/19/2025 · 10:02 AM

NEXLETOL Gains Approval in Japan: A Major Global Expansion for Esperion

Esperion's cholesterol pill, NEXLETOL, is now approved in Japan through its partner, Otsuka. This major global expansion (now U.S., Europe, Japan) secures Esperion large milestone payments and tiered royalties (15%-30%) on sales.

/ Subscriber only
/ Read more

Feed↓

Sidus Space Strengthens Cash Position but Posts Lower Revenue and Higher Cash Burn in Q2 2026
08/14/2026 · 5:31 PM

Sidus Space Strengthens Cash Position but Posts Lower Revenue and Higher Cash Burn in Q2 2026

Sidus Space reported Q2 2026 revenue of $583,000 (−54% YoY) due to contract timing, a $5.1M adjusted EBITDA loss, $166.5M cash, and key LizzieSat milestones.

/ Subscriber only
Diana Shipping Ends Nine-Month Pursuit of Genco Amid Valuation Standoff
08/14/2026 · 5:06 PM

Diana Shipping Ends Nine-Month Pursuit of Genco Amid Valuation Standoff

Diana Shipping walks away from Genco deal as board demands a 57% premium and nearly half the combined company.

/ Subscriber only
PayPal Weighs Higher Offer from Stripe and Advent International
Featured/ 08/14/2026 · 4:09 PM

PayPal Weighs Higher Offer from Stripe and Advent International

Stripe & Advent may raise their $53B+ bid for PayPal. Negotiations continue—no deal finalized amid valuation and regulatory concerns.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe